Skip to content

Medical-device intelligence

LFH: U.V. Spectrometry, Tricyclic Antidepressant Drugs

FDA product code LFH: U.V. Spectrometry, Tricyclic Antidepressant Drugs. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LFH
FDA device name
U.V. Spectrometry, Tricyclic Antidepressant Drugs
Device class
2
Regulation number
862.3910
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

6 clearance records and 3 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Nov 22, 1995 to Nov 17, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LFH · U.V. Spectrometry, Tricyclic Antidepressant Drugs63

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity c Tricyclic Antidepressants Reagent KitK231020 · LFHMicrogenics Corporation510(k)Nov 17, 2023FDA decision date
DRI TM Tricyclics Serum Tox AssayK213875 · LFHMicrogenics Corporation510(k)Dec 21, 2022FDA decision date
Alere iScreen Dx Urine Drug Screen CardZ-1542-2018 · LFHAmeditech IncRecallApr 28, 2018FDA record creation date
Alere iScreen Dx Urine Drug Screen Card, 20 Drug Detection, Kit Contents include 26 individually pouched devices and 1 IFU insert. The Alere iSc…Z-3084-2017 · LFHAmeditech IncRecallAug 29, 2017FDA record creation date
ADx Tricyclic Antidepressants Reagent. Distributed under the following label: ADx Tricyclic Antidepressants Reagents, Abbott Laboratories USA, No…Z-0324-04 · LFHAbbott Health Products, Inc.RecallJan 10, 2004FDA classification date
MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAYK983268 · LFHDiagnostic Reagents, Inc.510(k)Nov 18, 1998FDA decision date
ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCAK981801 · LFHPrinceton BioMeditech Corp.510(k)Aug 25, 1998FDA decision date
TRICYCLICS SERUM TOX ASSAYK961393 · LFHDiagnostic Reagents, Inc.510(k)Jun 12, 1996FDA decision date
AXSYM TRICYCLIC ANTIDEPRESSANTSK953761 · LFHAbbott Laboratories510(k)Nov 22, 1995FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗